Emergent BioSolutions' CEO Discusses Q3 2011 Results - Earnings Call Transcript

Emergent BioSolutions Inc. (NYSE:EBS) Q3 2011 Earnings Call November 3, 2011 5:00 PM ET

Executives

Robert Burrows – VP, IR
Fuad El-Hibri – Chairman and CEO
Don Elsey – SVP, Finance & Administration and CFO

Analysts

Karen Jay
Nicholas Bishop
Greg Wade
Jim Molloy

Operator

Good day, ladies and gentlemen, and welcome to the Third Quarter 2011 Emergent BioSolutions Incorporated Earnings Conference Call. My name is Ann and I’ll be your coordinator for today’s call. As a reminder this conference is being recorded for replay purposes. At this time all participants are in listen-only mode. (Operator Instructions)

I’d like to turn the presentation over to Mr. Robert Burrows. Please proceed sir.

Robert Burrows

Thank you, Ann. Good afternoon ladies and gentlemen. Again, my name is Robert Burrows, I’m Vice President of Investor Relations for Emergent. Thank you for joining us today, as we discuss Emergent BioSolutions’ financial results for the third quarter and full nine months of 2011. As is customary, our call today is open to all participants. In addition, the call is being recorded and is copyrighted by Emergent BioSolutions.

Joining me on the call this afternoon with prepared comments will be Fuad El-Hibri, Our Chairman and Chief Executive Officer and Don Elsey, our Chief Financial Officer. Additional members of our senior management team will be present on the call for purposes of the Q&A session.

Before we begin, I’m compelled to remind everyone that during the call, management may make projections and other forward-looking statements regarding future events and the company’s prospects or future performance. These forward-looking statements reflect Emergent’s current perspective on existing trends and information. Any such forward-looking statements are not guarantees of future performance and involve substantial risks and uncertainties. Actual results may differ materially from those projected in any forward-looking statements. You are encouraged to review Emergent’s filings